Clinical Trial Update: Study of IBI343 in Subjects With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for IBI343 in advanced gastric/gastroesophageal junction adenocarcinoma (no current status).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• IBI343

Snippet

Sponsor: Harbin Medical University | Conditions: Advanced Gastric/Gastroesophageal Junction Adenocarcinoma | Phase 2 | Status: UNKNOWN